The Medical Research Agency (ABM) has prepared a project to develop a SARS-CoV-2 coronavirus vaccine. Its purpose is to include Polish research centers in global research in this field.

In view of the epidemiological threat, the Medical Research Agency must react quickly by creating a dedicated program that will initiate the participation of Polish scientists in international projects in the field of research on the vaccine against CoV-2 – said Radosław Sierpiński, President of ABM.

Representatives of the Agency are currently negotiating the project assumptions with the National Institutes of Health (NIH) and Dr Anthony S. Fauci – director of the Institute of Infectious Diseases in Washington, DC, with European Commission agencies and medical universities in Europe, as well as with the Chinese embassy.